Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04002583 · ClinicalTrials.gov registry record · NA
48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease
A NA study of Early Onset Alzheimer Disease, sponsored by Mayo Clinic.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04002583 is a NA study of Early Onset Alzheimer Disease that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 637-participant average among 3 other Early Onset Alzheimer Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04002583, a NA study of Early Onset Alzheimer Disease, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are trying to determine the frequency of seizures and epilepsy in patients with Early-onset Alzheimer's disease (EOAD) using a 48-hour computer assisted ambulatory electroencephalogram.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Computer assisted ambulatory electroencephalogram
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-02-19 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04002583
The ClinicalTrials.gov registry entry for NCT04002583 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 637-participant average among 3 other Early Onset Alzheimer Disease trials with a reported enrollment target (97% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Early Onset Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Computer assisted ambulatory electroencephalogram is the first listed.
NCT04002583 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04002583 about?
NCT04002583 is a clinical study titled "48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease". Researchers are trying to determine the frequency of seizures and epilepsy in patients with Early-onset Alzheimer's disease (EOAD) using a 48-hour computer assisted ambulatory electroencephalogram.
What is the current status of trial NCT04002583?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2020-02-19. Estimated completion is 2026-12.
What conditions does trial NCT04002583 study?
This clinical trial studies the following conditions: Early Onset Alzheimer Disease.
What interventions are being tested in trial NCT04002583?
The interventions under investigation include: Computer assisted ambulatory electroencephalogram (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04002583?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04002583 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Early Onset Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.